On a continuing basis Emmeplus Life Science team monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the World and particularly USA, Israel, India, United Arab Emirates, European Union and the 27 Member States. This issue presents the following stories: USA Center For Drug Evaluation and Research – Guidance Documents The Challenges [...]
On a continuing basis Emmeplus Life Science team monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the World and particularly within USA, Israel, India, UAE, European Union and the 27 Member States. This issue presents the following stories: USA Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Guidance [...]
On a continuing basis Emmeplus Life Science team monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the World and particularly USA, Israel, India, United Arab Emirates, European Union and the 27 Member States. This issue presents the following stories: USA Guidance for Industry: Process Validation: General Principles and Practices List of [...]
On a continuing basis Emmeplus Life Science team monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the World and particularly USA, Israel, India, United Arab Emirates, European Union and the 27 Member States.
On a continuing basis Emmeplus Life Science team monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the World and particularly USA, Israel, India, United Arab Emirates, European Union and the 27 Member States.
On a continuing basis Emmeplus Life Science team monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the World and particularly in USA, Israel, India United Arab Emirates, the European Union and the 27 Member States. This month our newsletter presents the following stories: USA Medical, Statistical, and Clinical Pharmacology Reviews of [...]
On a continuing basis Emmeplus Life Science Department monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the European Union. This includes activities both at the EU Commission level, and also national developments within the 27 member countries. This month our newsletter presents the following stories: EUROPE Guideline on the Investigation [...]
On a continuing basis Emmeplus Life Science Department monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the European Union. This includes activities both at the EU Commission level, and also national developments within the 27 member countries. This month our newsletter presents the following stories: EUROPE Work programme 2010 [...]
On a continuing basis our Life Science Department monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the European Union. This includes activities both at the EU Commission level..
On a continuing basis our Life Science Department monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the European Union including EU Commission and national implementation levels.
On a continuing basis our Life Science Department monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the European Union including EU Commission and national implementation levels.
On a continuing basis our Life Science Department monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the European Union including EU Commission and national implementation levels.